Publicly listed biopharma company focused on oral immunotherapy utilizing polyclonal antibody products that target the human gut immune system & gut microbiome
Immuron Limited (ASX:IMC) (NASDAQ:IMRN) has continued to expand its presence in the digestive health market through growing sales, commercialisation activities, and portfolio expansion initiatives.
zurl.co/qDXJH#NASDAQ#IMRN#IMC#ASX#KalkineMediaAU#Immuron
We've just posted the following update on our investor hub: Emerging Growth Conference 92 - 8th May 2026: Immuron Limited (NASDAQ:IMRN)
Check out the full update and join in with the conversation at: investors.immuron.com.au/act…#ASX#IMC#NASDAQ#IMRN
We've just released the following announcement: Emerging Growth Conference
Check out the full announcement and join in with the conversation at: investors.immuron.com.au/ann…#imc
$IMRN Live Emerging Growth Conference 92 - May 6 & 7
@ImmuronLtd
Register:
goto.webcasts.com/starthere.…
Questions for the Company? Questions@EmergingGrowth.com
To Present on the Conference:
305-330-1985
Conference@EmergingGrowth.com
We've just released the following announcement: Immuron Double Digit 3Q Sales Growth
Check out the full announcement and join in with the conversation at: investors.immuron.com.au/ann…#imc
We've just released the following announcement: Small Holding Share Sale Facility
Check out the full announcement and join in with the conversation at: investors.immuron.com.au/ann…#imc
We've just released the following announcement: Presentation to Coffee Microcaps Conference
Check out the full announcement and join in with the conversation at: investors.immuron.com.au/ann…#imc
FDA greenlight: @ImmuronLtd secures approval for IMM-529 C. diff trial targeting US$400M peak sales opportunity as global sales hit $4.2M, up 5%. $IMCstockwirex.com/asx-stock-new…
@ImmuronLtd secures FDA approval to trial its C-diff infection drug while posting 5% global sales growth to $4.2M in HY26. $IMC ⚡
We've broken down the full announcement in the video above.
Highlights:
👉 $10M cash on hand = 23.5 months runway
#ASX#StockMarket#Investing
We've just released the following announcement: Strategic Update and HY26 Results
Check out the full announcement and join in with the conversation at: investors.immuron.com.au/ann…#imc
We've just released the following announcement: Appendix 4D and Half Year Report
Check out the full announcement and join in with the conversation at: investors.immuron.com.au/ann…#imc
We've just released the following announcement: Emerging Growth Conference Presentation
Check out the full announcement and join in with the conversation at: investors.immuron.com.au/ann…#imc
We've just released the following announcement: Immuron Continued Sales Growth
Check out the full announcement and join in with the conversation at: investors.immuron.com.au/ann…#imc
$IMRN Live Emerging Growth Conference 89 - January 21 & 22
@ImmuronLtd
Register:
goto.webcasts.com/starthere.…
Questions for the Company? Questions@EmergingGrowth.com
To Present on the Conference:
305-330-1985
Conference@EmergingGrowth.com